Evidence map›Paper›PMID 33981344›Full record

ArticleStem cells international2021

Corrigendum to "Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro".

Bishao Sun, Xing Luo, Chengfei Yang, Peilin Liu, Yang Yang, Xingyou Dong, Zhenxing Yang, JieXu, Yuanyuan Zhang, Longkun Li

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cells international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Bishao SunDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.ORCID https://orcid.org/0000-0003-3962-5043
Xing LuoDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Chengfei YangDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Peilin LiuDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Yang YangDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.ORCID https://orcid.org/0000-0002-2046-3542
Xingyou DongDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Zhenxing YangDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
JieXuDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.ORCID https://orcid.org/0000-0001-6700-7096
Yuanyuan ZhangWake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina 27157, USA.ORCID https://orcid.org/0000-0002-5708-9718
Longkun LiDepartment of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.ORCID https://orcid.org/0000-0003-3939-5647

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1155/2019/8035076.].

Identifiers

PMID33981344
PMCPMC8088368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.